SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Philippa C. Matthews, Anna Maria Geretti, Philip J.R. Goulder, Paul Klenerman, Epidemiology and impact of HIV coinfection with Hepatitis B and Hepatitis C viruses in Sub-Saharan Africa, Journal of Clinical Virology, 2014, 61, 1, 20

    CrossRef

  2. 2
    Yang Liu, Scott Fung, Edward J. Gane, Phillip Dinh, John F. Flaherty, Evguenia S. Svarovskaia, Michael D. Miller, Kathryn M. Kitrinos, Evaluation of HBV DNA decay kinetics in patients containing both rtM204V/I mutant and wild-type HBV subpopulations during tenofovir DF (TDF) monotherapy or combination therapy with emtricitabine (FTC)/TDF, Journal of Medical Virology, 2014, 86, 9
  3. 3
    Anders Boyd, Joël Gozlan, Sarah Maylin, Constance Delaugerre, Gilles Peytavin, Pierre-Marie Girard, Fabien Zoulim, Karine Lacombe, Persistent viremia in human immunodeficiency virus/hepatitis B coinfected patients undergoing long-term tenofovir: Virological and clinical implications, Hepatology, 2014, 60, 2
  4. 4
    Anders Boyd, Sarah Maylin, Joël Gozlan, Constance Delaugerre, François Simon, Pierre-Marie Girard, Karine Lacombe, Use of hepatitis B surface and “e” antigen quantification during extensive treatment with tenofovir in patients co-infected with HIV-HBV, Liver International, 2014, 34, 10
  5. 5
    Uma Devi, Stephen Locarnini, Hepatitis B antivirals and resistance, Current Opinion in Virology, 2013, 3, 5, 495

    CrossRef

  6. 6
    Fabien Zoulim, Barbara Testoni, Fanny Lebossé, Kinetics of Intrahepatic Covalently Closed Circular DNA and Serum Hepatitis B Surface Antigen During Antiviral Therapy for Chronic Hepatitis B: Lessons From Experimental and Clinical Studies, Clinical Gastroenterology and Hepatology, 2013, 11, 8, 1011

    CrossRef